C12N 2770/32334
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2770/32334 (Use of virus or viral component as vaccine) appears on 58 US grants and 77 published applications in this corpus.
Search patents in C12N- Granted patents
- 58
- Published applications
- 77
- Assignees
- 52
- Inventors
- 219
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 5 | 0 |
| 2001 | 3 | 1 |
| 2002 | 0 | 3 |
| 2003 | 0 | 1 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 5 |
| 2013 | 0 | 3 |
| 2014 | 0 | 2 |
| 2015 | 2 | 6 |
| 2016 | 0 | 6 |
| 2017 | 3 | 5 |
| 2018 | 6 | 10 |
| 2019 | 10 | 6 |
| 2020 | 6 | 4 |
| 2021 | 2 | 5 |
| 2022 | 4 | 4 |
| 2023 | 3 | 4 |
| 2024 | 2 | 4 |
| 2025 | 5 | 2 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Click outer membrane vesicles16 Jun 2026US 12,653,882 B2Intravacc B.V.
- Viral vector delivery system for both respiratory and digestive tracts of pigs and application thereof26 Aug 2025US 12,397,049 B2Guotai (Taizhou) Center of Technology Innovation for Veterinary Biologicals, Taizhou
- Adapted enterovirus D68 that propagates to high titer in vero cells6 May 2025US 12,290,555 B2Bharat Biotech International Limited
- Engineered Hansenula fungi efficiently expressing CA10 virus-like particles and uses thereof18 Mar 2025US 12,251,435 B2Beijing Minhai Biotechnology Co., Ltd.
- Recombinant viral vector, immune composition containing same, and use thereof14 Jan 2025US 12,195,517 B2Vacdiagn Biotechnology Co., Ltd
- Bivalent inactivated ev71-ca16 vaccine, method for preparing the same, and use thereof12 Mar 2026US 2026/0069673 A1Aim Action Biopharm Co., Ltd
- Coxsackievirus B Compositions and Methods Of Use Thereof20 Nov 2025US 2025/0352634 A1Vactech Oy
- Viral vector delivery system for both respiratory and digestive tracts of pigs and application thereof1 May 2025US 2025/0134983 A1Guotai (Taizhou) Center of Technology Innovation for Veterinary Biologicals, Taizhou
- Multi-cbv vaccine for preventing or treating type i diabetes12 Dec 2024US 2024/0408189 A1Vactech Oy
- Compositions and methods for enhanced antigen binding proteins15 Aug 2024US 2024/0269256 A1HDT Bio Corp.
Most cited
By later US patents
- Recombianant Hepatitis a virus59US 5,294,548 AAmerican Biogenetic Sciences, Inc. · 1994
- Method for inducing a systemic immune response to an antigen32US 6,015,576 ABio-Sphere Technology, Inc. · 2000
- Method for inducing a systemic immune response to an HIV antigen23US 6,207,185 B1Bio-Sphere Technology, Inc. · 2001
- Method for inducing a systemic immune response to a hepatitis antigen19US 6,117,449 ABio-Sphere Technology, Inc. · 2000
- Coxsackie virus as a vector for delivery of anti-inflammatory cytokines16US 6,071,742 ABoard of Regents of the University of Nebraska · 2000